Inland Empire Clinical Trials

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease	Recruiting	Phase 2	2026-10-08		NCT05519475
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk	Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Hepadnaviridae infectious disease, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, cirrhosis of liver, epithelial neoplasm, hepatitis, hepatitis B virus infection, hepatocellular carcinoma, infectious disease, liver cancer, liver disorder, neoplasm, viral hepatitis, viral infectious disease	Active, not recruiting	Not stated	2025-10-15		NCT05064553

Clinical trials